Qalys Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Kathua, Jammu & Kashmir, India, established in 2021.
2021 Kathua, Jammu & Kashmir, India Active
Last Updated:
Access Report
About Qalys Pharma Llp

Qalys Pharma Llp, a active limited liability partnership, was established on 08 June 2021 in Kathua, Jammu & Kashmir, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAX-3192. Registered under ROC Roc Jammu. It has total obligation of contribution of ₹1.00 Cr.

Its leadership includes Aryan Mahajan (Designated Partner), Rajiv Syal (Designated Partner), Rashmi Sharma (Designated Partner). It holds ₹38.05 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at 899/3, Sidco Industrial Complex, Ghatti, Kathua, Jammu & Kashmir, 184143.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAX-3192

  • Incorporation Date

    08 June 2021

  • Total Obligation of Contribution

    ₹1.00 Cr

  • ROC Code

    Roc Jammu

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 1.00 Cr
  • Company Age 4 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 38.05 Cr
Company report

Qalys Pharma Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Qalys Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Qalys Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Aryan Mahajan Designated Partner 08 Jun 2021 Current
Rajiv Syal Designated Partner 20 Dec 2023 Current
Rashmi Sharma Designated Partner 20 Dec 2023 Current
Rajesh Mahajan Designated Partner 08 Jun 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Qalys Pharma Llp.

Enhance accessibility to Qalys Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Qalys Pharma Llp revenue growth over time
Qalys Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Qalys Pharma Llp?

Unlock access to Qalys Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹380,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 38.05 Cr
Latest Charge Details
Date Lender Amount Status
23 Sep 2024 Hdfc Bank Limited ₹38.05 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Qalys Pharma Llp?

Unlock and access historical data on people associated with Qalys Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Qalys Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qalys Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Qalys Pharma Llp
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 38.05 Cr registered on 23 Sep 2024 with Charge ID 100981658 was modified on 02 Aug 2025. was documented.

  • Annual General Meeting

    The activity Qalys Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Qalys Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jammu. was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 38.05 Cr with Charge ID 100981658 was registered on 23 Sep 2024. was recorded as a recent event.

  • Director Appointment

    The activity Rajiv Syal was appointed as a Designated Partner was appointed as a Designated Partner on 20 Dec 2023 & has been associated with this company since 2 years 4 months . was completed.

  • Director Appointment

    Rashmi Sharma was appointed as a Designated Partner was appointed as a Designated Partner on 20 Dec 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Qalys Pharma Llp?

The LLPIN of Qalys Pharma Llp is AAX-3192.

Where is Qalys Pharma Llp headquartered?

Qalys Pharma Llp is headquartered at 899/3, Sidco Industrial Complex, Ghatti, Kathua, Jammu & Kashmir, 184143.

When was Qalys Pharma Llp incorporated?

Qalys Pharma Llp was incorporated on 08 June 2021.

Who are the current directors of Qalys Pharma Llp?

The current directors of Qalys Pharma Llp are

What is the primary industry of Qalys Pharma Llp?

The primary industry of Qalys Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available